E2F1 and metabolic dysfunction-associated steatotic liver disease: The results revealed that E2F1 had the highest binding free energy to dehydrovomifoliol compared to the other protein molecules, indicating that dehydrovomifoliol may participate in related mechanistic responses by regulating E2F1 protein in NAFLD treatment.